These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18817363)

  • 21. α₁-Adrenoceptor and serotonin 5-HT(1A) receptor affinity of homobivalent 4-aminoquinoline compounds: an investigation of the effect of linker length.
    Chen J; Murad AK; Wakelin LP; Denny WA; Griffith R; Finch AM
    Biochem Pharmacol; 2013 May; 85(10):1534-41. PubMed ID: 23524075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships in 1,4-benzodioxan-related compounds. 5. Effects of modification of the side chain on alpha-adrenoreceptor blocking activity.
    Quaglia W; Giannella M; Marucci G; Piergentili A; Pigini M; Tayebati SK; Melchiorre C
    Farmaco; 1996 Jan; 51(1):27-32. PubMed ID: 8721758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in alpha1-adrenoreceptor antagonists as pharmacological tools and therapeutic agents.
    Rosini M; Bolognesi ML; Giardinà D; Minarini A; Tumiatti V; Melchiorre C
    Curr Top Med Chem; 2007; 7(2):147-62. PubMed ID: 17266603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.
    Quaglia W; Pigini M; Tayebati SK; Piergentili A; Giannella M; Leonardi A; Taddei C; Melchiorre C
    J Med Chem; 1996 May; 39(11):2253-8. PubMed ID: 8667368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
    Zhao MM; Hwa J; Perez DM
    Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
    Bolognesi ML; Budriesi R; Chiarini A; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1998 Nov; 41(24):4844-53. PubMed ID: 9822553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.
    Sorbi C; Franchini S; Tait A; Prandi A; Gallesi R; Angeli P; Marucci G; Pirona L; Poggesi E; Brasili L
    ChemMedChem; 2009 Mar; 4(3):393-9. PubMed ID: 19152363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel naftopidil-related derivatives and their biological effects as alpha1-adrenoceptors antagonists and antiproliferative agents.
    Huang J; He F; Huang M; Liu X; Xiong Y; Huang Y; Zhu L; Yang Y; Xu X; Yuan M
    Eur J Med Chem; 2015; 96():83-91. PubMed ID: 25874333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors.
    Franchini S; Battisti UM; Baraldi A; Prandi A; Fossa P; Cichero E; Tait A; Sorbi C; Marucci G; Cilia A; Pirona L; Brasili L
    Eur J Med Chem; 2014 Nov; 87():248-66. PubMed ID: 25261823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
    Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
    Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Multi-target Antagonists of α1A-, α1D-Adrenoceptors and 5-HT1A Receptors Reduce Human Hyperplastic Prostate Cell Growth and the Increase of Intraurethral Pressure.
    Nascimento-Viana JB; Carvalho AR; Nasciutti LE; Alcántara-Hernández R; Chagas-Silva F; Souza PA; Romeiro LA; García-Sáinz JA; Noël F; Silva CL
    J Pharmacol Exp Ther; 2016 Jan; 356(1):212-22. PubMed ID: 26493747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QSAR study for a novel series of ortho monosubstituted phenoxy analogues of alpha1-adrenoceptor antagonist WB4101.
    Fumagalli L; Bolchi C; Colleoni S; Gobbi M; Moroni B; Pallavicini M; Pedretti A; Villa L; Vistoli G; Valoti E
    Bioorg Med Chem; 2005 Apr; 13(7):2547-59. PubMed ID: 15755656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and alpha-adrenoreceptor blocking properties of phenoxybenzamine-related (2-chloroethyl)-(2,3-dihydrobenzo[1,4]dioxin- 2-ylmethyl)-(2-phenoxyethyl) amines.
    Giardinà D; Crucianelli M; Marucci G; Paparelli F; Melchiorre C
    Bioorg Med Chem; 1995 Jan; 3(1):85-94. PubMed ID: 8612050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
    Shibata K; Foglar R; Horie K; Obika K; Sakamoto A; Ogawa S; Tsujimoto G
    Mol Pharmacol; 1995 Aug; 48(2):250-8. PubMed ID: 7651358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).
    Pallavicini M; Budriesi R; Fumagalli L; Ioan P; Chiarini A; Bolchi C; Ugenti MP; Colleoni S; Gobbi M; Valoti E
    J Med Chem; 2006 Nov; 49(24):7140-9. PubMed ID: 17125266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.
    Childers WE; Abou-Gharbia MA; Kelly MG; Andree TH; Harrison BL; Ho DM; Hornby G; Huryn DM; Potestio L; Rosenzweig-Lipson SJ; Schmid J; Smith DL; Sukoff SJ; Zhang G; Schechter LE
    J Med Chem; 2005 May; 48(10):3467-70. PubMed ID: 15887953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.
    Perez DM; Piascik MT; Malik N; Gaivin R; Graham RM
    Mol Pharmacol; 1994 Nov; 46(5):823-31. PubMed ID: 7969068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spiroxatrine derivatives towards 5-HT
    Sorbi C; Tait A; Battisti UM; Brasili L
    Pharmacol Rep; 2020 Apr; 72(2):427-434. PubMed ID: 32002826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.